Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Chemotherapy in tablet form. | Cuts off a tumour's blood supply. |
| Body system | Cancer | Cancer |
| Drug class | Antimetabolites | Targeted antibodies |
| Supply | Prescription onlyWHO essential medicine | Prescription only |
| Main uses | Bowel cancer, Breast cancer, Stomach and oesophageal cancer, With radiotherapy for rectal cancer | Bowel cancer, Lung cancer, Ovarian and cervical cancer, Glioblastoma, Wet macular degeneration (off-label eye injections) |
| How it works | Becomes chemotherapy mainly inside cancer tissue. | Stops tumours growing the blood vessels they need. |
| Starts working | — | — |
| Half-life | — | About 20 days |
| Typical adult dose | Usually 1,000–1,250 mg/m² twice a day for 14 days of each 21-day cycle. | 5–15 mg/kg IV every 2–3 weeks depending on cancer. |
| Forms | Tablet | IV infusion, Intravitreal injection (ophthalmic forms in some countries) |
| Common side effects | Sore, red, peeling hands and feet, Diarrhoea, Nausea, Tiredness | High blood pressure, Protein in urine, Nosebleeds, Tiredness |
| Serious side effects | Severe diarrhoea and dehydration, Low blood counts, Fatal toxicity with DPD deficiency, Chest pain (coronary spasm) | Bowel perforation, Bleeding, Poor wound healing, Clots |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Usually avoidedCan harm the fetus. | Usually avoidedContraception for 6 months after. |
| Breastfeeding | — | — |
| In use since | 1998 | 2004 |
| Brand names | United States: XelodaUnited Kingdom: Xeloda, EcansyaIndia: Capegard, Xeloda | United States: Avastin, Mvasi, ZirabevUnited Kingdom: Avastin, AlymsysIndia: Bevatas, Abevmy |
| Legal status | — | — |
| ATC code | L01BC06 | L01FG01 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker